direct carginogen

use factor | U | beam direction factor

Definition: This category differs from others in that it includes disorders identifiable on the basis of not only symptoms and course but also the existence of one or other of two causative influences: an exceptionally stressful life event producing an acute stress reaction, or a significant life change leading to continued unpleasant circumstances that result in an adjustment disorder. Although less severe psychosocial stress ( life events ) may precipitate the onset or contribute to the presentation of a very wide range of disorders classified elsewhere in this chapter, its etiological importance is not always clear and in each case will be found to depend on individual, often idiosyncratic, vulnerability, i.e. the life events are neither ...[+++] necessary nor sufficient to explain the occurrence and form of the disorder. In contrast, the disorders brought together here are thought to arise always as a direct consequence of acute severe stress or continued trauma. The stressful events or the continuing unpleasant circumstances are the primary and overriding causal factor and the disorder would not have occurred without their impact. The disorders in this section can thus be regarded as maladaptive responses to severe or continued stress, in that they interfere with successful coping mechanisms and therefore lead to problems of social functioning.

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Technical Working Group 8 Carcinogens in the Context of Council Directive 96/82/EC | TWG8 [Abbr.]

Definition: Disorders of adult personality and behaviour that have developed in persons with no previous personality disorder following exposure to catastrophic or excessive prolonged stress, or following a severe psychiatric illness. These diagnoses should be made only when there is evidence of a definite and enduring change in a person's pattern of perceiving, relating to, or thinking about the environment and himself or herself. The personality change should be significant and be associated with inflexible and maladaptive behaviour not present before the pathogenic experience. The change should not be a direct manifestation of another ...[+++] mental disorder or a residual symptom of any antecedent mental disorder.

Selective factor Xa inhibitor

Proximate determinant of fertility

Patterns and Trends in Technology Licensing and Foreign Direct Investment: Emperical Studies of Their Determinants

diffuse-direct solar radiation factor

24. Calls for review Directive 2004/37 on the protection of workers against risks associated to the exposure of Carcinogens and Mutagens at work; stresses that the scope of that Directive needs to be extended to take into account new risk factors;

40. Expresses regret at the lack of a proposal and initiatives in the public health field and calls on the Commission to bring forward a legislative proposal on advanced therapy medicinal products; welcomes the Commission's intention to amend, in 2012, Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work; stresses that new factors and dates point to the need for a change and therefore urges the Commission to present the amending act as a matter of urgency, while also ...[+++] considering an extension of the scope of that directive in order to diminish the risk from substances toxic to reproduction and their presence in products, and to safeguard health and safety at work for European workers;

23. Welcomes the Commission’s intention to amend in 2012 the Directive 2004/37 concerning protection of workers against the risk associated to the exposure to carcinogens and mutagens at work; stresses that new factors and dates indicate a need for a change and therefore urges the Commission to present the amending act as a matter of urgency also assessing the extension of the scope of the Directive in order to diminish the risk and substances that are toxic for reproduction and safeguard health and safety at work for Europeans worke ...[+++]rs;

36. Expresses regret at the lack of a proposal and initiatives in the public health field and calls on the Commission to bring forward a legislative proposal on advanced therapy medicinal products; welcomes the Commission’s intention to amend, in 2012, Directive 2004/37 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work; stresses that new factors and dates point to the need for a change and therefore urges the Commission to present the amending act as a matter of urgency, while also co ...[+++]nsidering an extension of the scope of that directive in order to diminish the risk from substances toxic to reproduction and their presence in products, and to safeguard health and safety at work for European workers;